Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9350608rdf:typepubmed:Citationlld:pubmed
pubmed-article:9350608lifeskim:mentionsumls-concept:C0016017lld:lifeskim
pubmed-article:9350608lifeskim:mentionsumls-concept:C0232989lld:lifeskim
pubmed-article:9350608lifeskim:mentionsumls-concept:C0392747lld:lifeskim
pubmed-article:9350608lifeskim:mentionsumls-concept:C0443172lld:lifeskim
pubmed-article:9350608pubmed:issue4lld:pubmed
pubmed-article:9350608pubmed:dateCreated1997-12-9lld:pubmed
pubmed-article:9350608pubmed:abstractTextThe aim of this study was to evaluate the changes in fibrinolysis parameters during pregnancy. Normal pregnant women (n = 60) formed the study population. Blood samples were taken in the first, second and third trimester, during delivery and three days after delivery. Fibrinolysis parameters were estimated using commercial tests. Tissue plasminogen activator, D-dimer and plasminogen activator inhibitors (PAI-1 and PAI-2) were determined. Tissue plasminogen activator and D-dimer increased after the first trimester and reached maximum levels during delivery. Plasminogen activator inhibitors type 1 and type 2 were also higher, in particular PAI-2, and reached maximum levels in the third trimester. On the third day after delivery, fibrinolysis activity recovered, but D-dimer and PAI-2 levels remained above the normal non-pregnant range.lld:pubmed
pubmed-article:9350608pubmed:languageenglld:pubmed
pubmed-article:9350608pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9350608pubmed:citationSubsetIMlld:pubmed
pubmed-article:9350608pubmed:statusMEDLINElld:pubmed
pubmed-article:9350608pubmed:issn0300-5577lld:pubmed
pubmed-article:9350608pubmed:authorpubmed-author:CaberoLLlld:pubmed
pubmed-article:9350608pubmed:authorpubmed-author:BorrellMMlld:pubmed
pubmed-article:9350608pubmed:authorpubmed-author:FontcubertaJJlld:pubmed
pubmed-article:9350608pubmed:authorpubmed-author:MirallesR MRMlld:pubmed
pubmed-article:9350608pubmed:authorpubmed-author:GilabertRRlld:pubmed
pubmed-article:9350608pubmed:authorpubmed-author:BellartJJlld:pubmed
pubmed-article:9350608pubmed:issnTypePrintlld:pubmed
pubmed-article:9350608pubmed:volume25lld:pubmed
pubmed-article:9350608pubmed:ownerNLMlld:pubmed
pubmed-article:9350608pubmed:authorsCompleteYlld:pubmed
pubmed-article:9350608pubmed:pagination368-72lld:pubmed
pubmed-article:9350608pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9350608pubmed:meshHeadingpubmed-meshheading:9350608-...lld:pubmed
pubmed-article:9350608pubmed:meshHeadingpubmed-meshheading:9350608-...lld:pubmed
pubmed-article:9350608pubmed:meshHeadingpubmed-meshheading:9350608-...lld:pubmed
pubmed-article:9350608pubmed:meshHeadingpubmed-meshheading:9350608-...lld:pubmed
pubmed-article:9350608pubmed:meshHeadingpubmed-meshheading:9350608-...lld:pubmed
pubmed-article:9350608pubmed:year1997lld:pubmed
pubmed-article:9350608pubmed:articleTitleFibrinolysis changes in normal pregnancy.lld:pubmed
pubmed-article:9350608pubmed:affiliationDepartment of Obstetrics and Gynecology, Joan XXIII University Hospital, Rovira i Virgili University, Tarragona, Spain.lld:pubmed
pubmed-article:9350608pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9350608pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed